Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

ME | 23andMe Holding Co

IndexRUT P/E- EPS (ttm)-0.72 Insider Own38.95% Shs Outstand293.02M Perf Week-2.23%
Market Cap461.95M Forward P/E- EPS next Y-0.60 Insider Trans-0.16% Shs Float288.46M Perf Month-14.98%
Income-326.75M PEG- EPS next Q-0.14 Inst Own23.29% Short Float / Ratio8.92% / 10.24 Perf Quarter-44.13%
Sales295.84M P/S1.56 EPS this Y6.17% Inst Trans6.98% Short Interest25.73M Perf Half Y-56.55%
Book/sh1.43 P/B0.68 EPS next Y6.66% ROA-33.80% Target Price4.50 Perf Year-69.64%
Cash/sh0.67 P/C1.46 EPS next 5Y- ROE-42.72% 52W Range0.96 - 3.50 Perf YTD-54.74%
Dividend- P/FCF- EPS past 5Y-8.86% ROI-43.51% 52W High-72.07% Beta1.38
Dividend %- Quick Ratio2.87 Sales past 5Y-21.82% Gross Margin35.32% 52W Low1.83% ATR0.08
Employees816 Current Ratio2.97 Sales Q/Q-5.66% Oper. Margin-114.75% RSI (14)38.37 Volatility8.16% 7.37%
OptionableYes Debt/Eq0.12 EPS Q/Q-12.87% Profit Margin-110.45% Rel Volume0.85 Prev Close1.02
ShortableYes LT Debt/Eq0.11 EarningsAug 08 AMC Payout- Avg Volume2.51M Price0.98
Recom1.67 SMA20-7.38% SMA50-26.23% SMA200-50.44% Volume2,145,204 Change-4.15%
Date Action Analyst Rating Change Price Target Change
Nov-29-22Initiated Berenberg Buy $7
Sep-22-22Initiated Cowen Outperform $6
Nov-15-21Downgrade Citigroup Buy → Neutral $12 → $13
Aug-17-21Initiated Credit Suisse Outperform $13
Jul-12-21Initiated Citigroup Buy $14
Sep-27-23 04:05PM
Sep-14-23 07:00AM
Sep-01-23 09:57AM
Aug-31-23 05:28PM
Aug-25-23 05:10AM
05:32AM Loading…
Aug-22-23 05:32AM
Aug-09-23 05:24PM
Aug-08-23 04:05PM
Jul-25-23 04:05PM
Jul-20-23 09:23AM
Jun-26-23 03:00AM
Jun-21-23 07:00AM
Jun-17-23 07:00AM
Jun-14-23 11:40AM
May-26-23 08:00AM
04:05PM Loading…
May-25-23 04:05PM
May-23-23 09:53AM
May-19-23 06:40AM
May-16-23 10:59AM
May-11-23 04:05PM
May-09-23 07:00AM
May-08-23 07:00AM
May-01-23 08:20PM
Apr-30-23 09:38PM
Apr-27-23 09:43AM
Apr-19-23 08:57AM
Apr-14-23 04:05PM
Apr-11-23 07:00AM
07:01AM Loading…
Mar-29-23 07:01AM
Mar-24-23 07:00AM
Mar-23-23 06:22AM
Mar-22-23 10:23AM
Mar-17-23 10:15AM
Mar-14-23 04:30PM
Mar-09-23 10:07AM
Mar-02-23 07:30AM
Mar-01-23 07:00PM
Feb-28-23 10:23AM
Feb-22-23 04:05PM
Feb-10-23 06:12AM
Feb-08-23 04:50PM
Feb-01-23 10:16AM
Jan-26-23 04:05PM
Jan-25-23 07:30AM
Jan-10-23 08:25AM
Dec-13-22 11:10AM
Dec-05-22 09:51AM
Dec-01-22 12:00PM
Nov-17-22 01:58PM
Nov-15-22 12:04PM
Nov-07-22 04:01PM
Oct-27-22 06:45AM
Oct-25-22 01:05PM
Oct-24-22 04:05PM
Oct-21-22 10:15AM
Oct-12-22 04:10PM
Oct-11-22 07:51AM
Oct-05-22 10:30AM
Sep-19-22 06:45AM
Sep-15-22 06:00AM
Sep-07-22 06:39AM
Sep-02-22 06:22AM
Aug-30-22 02:48PM
Aug-25-22 12:10PM
Aug-19-22 08:43AM
Aug-16-22 09:03AM
Aug-11-22 02:58PM
Aug-08-22 04:05PM
Aug-03-22 08:15AM
Jul-25-22 04:05PM
Jul-11-22 02:03PM
Jul-08-22 10:18AM
Jul-01-22 06:00AM
Jun-17-22 03:27PM
Jun-08-22 09:03PM
Jun-02-22 07:32AM
May-27-22 02:28PM
May-26-22 06:51PM
May-24-22 06:30AM
May-12-22 04:10PM
May-03-22 03:04PM
Apr-29-22 03:35PM
Apr-10-22 06:00AM
Apr-06-22 06:11PM
23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HIBBS KATHY LChief Administrative OfficerSep 21Option Exercise0.4238,54816,1901,323,524Sep 25 04:00 PM
HIBBS KATHY LChief Administrative OfficerSep 21Sale1.0038,54838,5831,284,976Sep 25 04:00 PM
HIBBS KATHY LChief Administrative OfficerSep 07Option Exercise0.4240,89417,175299,880Sep 11 04:04 PM
HIBBS KATHY LChief Administrative OfficerSep 07Sale1.0640,89443,483258,984Sep 11 04:04 PM
Richards William GHead of Therapeutics DiscoverySep 05Sale1.082,5382,741211,041Sep 06 05:01 PM
HIBBS KATHY LChief Administrative OfficerAug 24Option Exercise0.4240,89417,175293,406Aug 25 04:57 PM
HIBBS KATHY LChief Administrative OfficerAug 24Sale1.0540,89443,119252,512Aug 25 04:57 PM
HIBBS KATHY LChief Administrative OfficerAug 15Option Exercise0.4240,89417,175298,034Aug 16 04:51 PM
HIBBS KATHY LChief Administrative OfficerAug 15Sale1.3240,89453,939257,140Aug 16 04:51 PM
HIBBS KATHY LChief Administrative OfficerJul 27Option Exercise0.4240,89417,175298,034Jul 31 04:23 PM
HIBBS KATHY LChief Administrative OfficerJul 27Sale1.8940,89477,257257,140Jul 31 04:23 PM
HIBBS KATHY LChief Administrative OfficerJul 13Option Exercise0.4240,89417,175298,034Jul 14 04:33 PM
HIBBS KATHY LChief Administrative OfficerJul 13Sale1.8240,89474,239257,140Jul 14 04:33 PM
HIBBS KATHY LChief Administrative OfficerJun 29Option Exercise0.4240,89417,175298,034Jun 30 04:22 PM
HIBBS KATHY LChief Administrative OfficerJun 29Sale1.7240,89470,432257,140Jun 30 04:22 PM
HIBBS KATHY LChief Administrative OfficerDec 05Sale3.2526,25985,342235,829Dec 06 05:44 PM
SCHELLER RICHARD HDirectorNov 11Sale3.2418,42159,68472,388Nov 14 04:38 PM